The Lancet: First-ever in-utero stem cell therapy for fetal spina bifida repair is safe, study finds
A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery ...
Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe. Spina bifida, a condition in which the ...
A first-in-human, phase I single-arm trial has found that in-utero treatment of myelomeningocele, the most severe form of spina bifida, using allogeneic live stem cells was both feasible and ...
The discovery of a gene essential to early embryonic development sheds light on the preliminary stages of human placenta formation. A team led by scientists from the University of California San Diego ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results